Corey Best

Cornelius L. Best is founder of YCORE of North Carolina, Inc., a biotech and pharmaceutical consulting firm. Corey is currently leading all aspects (including project management and clinical management) of clinical trial conduct for a biotech company in New York. He has a depth of experience in global pharmaceutical research with expertise in operations, program and life cycle management, and organization development. Corey is known as a "solutions architect.” While at Otsuka Pharmaceuticals, he led more than 100 colleagues of various professional disciplines, cultures, organizations, and time zones to successfully complete a 60M USD global clinical development program for an anti-tuberculosis compound, one of the first major multinational clinical programs to evaluate treatment of multi-drug resistant tuberculosis.

For over 15 years, Corey has guided global clinical trials in the development of new pharmaceutical products, including directing all phases of high-impact clinical trials. He has developed cultural literacy by working in Africa, Asia, Europe, and South America.  Corey is a graduate of Campbell University, with a BS in Pharmaceutical Sciences and an MS in Clinical Research. He also holds an MBA from The Fuqua School of Business at Duke University. Corey is a fellow of the Emerging Leaders in Public Health through the Gillings School of Public Health and the Kenan-Flagler School of Business at UNC-Chapel Hill. He is a credentialed member of the Project Management Institute (PMI). 

He currently serves on the Dean's Board of Advisors for the College of Pharmacy & Health Sciences at Campbell University. In addition, he is a director on the board of the NCCU Foundation, Inc.  Corey is a member of CALIBR, a global leadership network that offers career and professional development, community service opportunities, and points of connectivity for business professionals. He resides in Chapel Hill, North Carolina with his wife and son.